1. Home
  2. VRCA vs CLAR Comparison

VRCA vs CLAR Comparison

Compare VRCA & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.26

Market Cap

117.5M

Sector

Health Care

ML Signal

HOLD

Logo Clarus Corporation

CLAR

Clarus Corporation

HOLD

Current Price

$3.36

Market Cap

104.9M

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRCA
CLAR
Founded
2013
1957
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
117.5M
104.9M
IPO Year
2018
1998

Fundamental Metrics

Financial Performance
Metric
VRCA
CLAR
Price
$6.26
$3.36
Analyst Decision
Buy
Buy
Analyst Count
2
3
Target Price
$17.00
$4.08
AVG Volume (30 Days)
38.9K
432.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
N/A
3.80%
EPS Growth
N/A
11.68
EPS
N/A
N/A
Revenue
$35,577,000.00
$228,000.00
Revenue This Year
N/A
$5.27
Revenue Next Year
$94.44
$3.99
P/E Ratio
N/A
N/A
Revenue Growth
370.22
N/A
52 Week Low
$0.72
$2.53
52 Week High
$9.82
$4.03

Technical Indicators

Market Signals
Indicator
VRCA
CLAR
Relative Strength Index (RSI) 52.37 67.03
Support Level $5.32 $3.28
Resistance Level $6.56 $3.53
Average True Range (ATR) 0.55 0.12
MACD 0.05 0.01
Stochastic Oscillator 59.02 96.34

Price Performance

Historical Comparison
VRCA
CLAR

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

About CLAR Clarus Corporation

Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and U.S.

Share on Social Networks: